Search Results - "TANSAN, SUALP"
-
1
Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations
Published in BMC cancer (03-06-2019)“…Hereditary cancer predisposition syndromes are responsible for approximately 5-10% of all diagnosed cancer cases. In the past, single-gene analysis of specific…”
Get full text
Journal Article -
2
Comprehensive tumor molecular profile analysis in clinical practice
Published in BMC medical genomics (14-04-2021)“…Tumor molecular profile analysis by Next Generation Sequencing technology is currently widely applied in clinical practice and has enabled the detection of…”
Get full text
Journal Article -
3
EML4-ALK-positive lung adenocarcinoma presenting an unusual metastatic pattern in a 29-year-old woman who is alive and well in her third year follow up:A case report
Published in Respiratory medicine case reports (01-01-2017)“…Non-small cell lung cancer (NSCLC) is a frequent tumor entity with high mortality. Although several newly discovered chromosomal translocations and mutations…”
Get full text
Journal Article -
4
Chemotherapy and radiofrequency hyperthermia (oncothermia) in the treatment of metastatic colorectal cancer
Published in Journal of clinical oncology (01-06-2023)“…e15569 Background: Colorectal cancer (CRC) is the second leading cause of death in adults. Standard treatment for metastatic disease includes chemotherapy and…”
Get full text
Journal Article -
5
Chemotherapy and radiofrequency hyperthermia in advanced ovarian cancer
Published in Journal of clinical oncology (01-06-2022)“…e17550 Background: Ovarian cancer (OC) is the the leading cause of cancer death in females. Most cases present at advanced stage. Standard treatment is…”
Get full text
Journal Article -
6
Correlation between D-dimer levels and clinical stage of solid tumors
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
7
Increasing targeted therapy options for mCRPC patients using multigene NGS panel
Published in Journal of clinical oncology (01-06-2023)“…e17056 Background: Prostate cancer (PCa) represents the second most common malignancy in males, characterized by a high level of clinical and molecular…”
Get full text
Journal Article -
8
Abstract P5-13-01: Comprehensive tumor analysis by NGS in metastatic breast cancer patients
Published in Cancer research (Chicago, Ill.) (15-02-2022)“…Abstract Background: Comprehensive tumor analysis by Next Generation Sequencing (NGS) is imperative for targeted and immunotherapy related biomarkers’ analysis…”
Get full text
Journal Article -
9
Abstract P2-09-10: Different CNVs account for 10.4% of pathogenic variants in 1418 patients referred for hereditary breast cancer testing
Published in Cancer research (Chicago, Ill.) (15-02-2022)“…Abstract Background: Breast cancer is the most frequently diagnosed cancer in women and about 10% of breast cancer cases are hereditary. BRCA1 and BRCA2 are…”
Get full text
Journal Article -
10
Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing
Published in Cancer genomics & proteomics (01-09-2023)“…Background/Aim: Germline copy number variation (CNV) is a type of genetic variant that predisposes significantly to inherited cancers. Today, next-generation…”
Get full text
Journal Article -
11
Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in Breast Cancer Patients
Published in Cancer genomics & proteomics (01-01-2022)“…The use of multi-gene panels for germline testing in breast cancer enables the estimation of cancer risk and guides risk-reducing management options. The aim…”
Get full text
Journal Article -
12
Clinical Utility of Functional RNA Analysis for the Reclassification of Splicing Gene Variants in Hereditary Cancer
Published in Cancer genomics & proteomics (01-05-2021)“…Background: Classification of splicing variants (SVs) in genes associated with hereditary cancer is often challenging. The aim of this study was to investigate…”
Get full text
Journal Article -
13
Mutation analysis of the BRCA1 and BRCA2 genes in Turkish patients with breast cancer
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
14
Chronic lymphocytic leukemia
Published in The American journal of the medical sciences (01-09-1994)Get more information
Journal Article -
15
EML4-ALK-positive lung adenocarcinoma presenting an unusual metastatic pattern in a 29-year-old woman who is alive and well in her third year follow up:A case report
Published in Respiratory medicine case reports (01-01-2017)“…Non-small cell lung cancer (NSCLC) is a frequent tumor entity with high mortality. Although several newly discovered chromosomal translocations and mutations…”
Get full text
Report -
16
Collection of mobilized blood progenitor cells for hematopoietic rescue by large-volume leukapheresis
Published in Transfusion (Philadelphia, Pa.) (01-06-1995)“…Mobilized blood progenitor cells rapidly reconstitute hematopoiesis in patients after dose-intensive chemotherapy. However, optimal timing and methods of…”
Get more information
Journal Article -
17
Augmentation of vincristine cytotoxicity by megestrol acetate
Published in Cancer chemotherapy and pharmacology (1997)“…To determine the effect of a semisynthetic progesterone, megestrol acetate (MA), on the cytotoxicity of various chemotherapeutic agents including vincristine,…”
Get full text
Journal Article -
18
Treatment of malignant pleural mesothelioma with cisplatin, mitomycin C and alpha interferon
Published in Oncology (01-07-1994)“…From October 1990 to September 1991, 20 consecutive patients with histologically proven malignant pleural mesothelioma (MPM), secondary to environmental…”
Get more information
Journal Article -
19
Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin C
Published in Cancer (01-02-1993)“…Treatment options for advanced non-small-cell lung cancer are inadequate. There remains a critical need for more effective systemic therapies. Forty-one…”
Get more information
Journal Article